HC2 Holdings Completes Sale of Continental Insurance Business for $90 Million
“This divestiture marks another key milestone in the transformation of HC2. Going forward our focus will be on our three core operating segments – Infrastructure, Life Sciences and Spectrum – all of which have best-in-class assets that are well positioned to thrive,” said
“The consummation of this deal increases the Company’s financial flexibility, better supports our remaining assets and positions us to drive growth,” said
“I believe completing this transaction helps HC2 meet its key strategic objectives while positioning Continental to strategically expand its footprint and pursue new opportunities,” added
The transaction was approved by the Board of Directors of HC2, excluding
For further information regarding the terms and conditions of the agreement, please refer to the transaction agreement filed on Form 8-K with the
Duff & Phelps served as financial advisor to HC2 in connection with the transaction and issued a fairness opinion to the Board of Directors of HC2 in connection with this transaction.
About HC2
About
Based in
Cautionary Statement Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release contains, and certain oral statements made by our representatives from time to time may contain, forward-looking statements regarding the sale of Continental by the Company and our expectations regarding building shareholder value, as well as those that may be identified by words such as “will,” “intend,” “expect,” “anticipate,” “should,” “could” and similar expressions, all of which involve risks, assumptions and uncertainties, many of which are outside of the Company’s control, and are subject to change. All forward-looking statements speak only as of the date made, and unless legally required, HC2 undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. HC2’s actual results could differ materially from those expressed or implied in the forward-looking statements due to a variety of important factors, both positive and negative, that may be revised or supplemented in subsequent statements and reports filed with the
FOR HC2:
Media Contact:
Reevemark
HC2@reevemark.com
(212) 433-4600
Investor Contact:
Solebury Trout
ir@hc2.com
(212) 235-2691
FOR CONTINENTAL:
MKA
gmarose@mkacomms.com
Source: HC2 Holdings, Inc.